Literature DB >> 8927030

Contractile effects of vanadate on aorta rings from virgin and pregnant rats.

J St-Louis1, B Sicotte, E Breton, A K Srivastava.   

Abstract

The present study was undertaken to characterize the contractile effects of vanadate on thoracic aorta rings from virgin and term-pregnant rats. Vanadate caused concentration-dependent contraction in rat aortic rings with an EC50 (concentration producing 50% maximum response) of 0.10 mM. Contractions in response to vanadate were equivalent to the ones measured with 1 microM phenylephrine. The effects of vanadate were not affected by indomethacin (up to 10 microM), an inhibitor of prostanoid cyclooxygenase, but were blocked in a concentration-dependent manner by staurosporine (0.1-1.0 microM), an inhibitor of protein kinase C. Vanadate exhibited a significant decrease of contractile responses in aorta of pregnant as compared to virgin rats. When aortic rings were bathed in presence of different concentrations of vanadate, the concentration-response curve to phenylephrine was shifted to the left, but maximum response was not affected. The potentiation of the contractions to phenylephrine by vanadate was significantly more prominent in aorta of virgin than of pregnant rats. These results suggest that the contractile effect of vanadate on rat aorta is independent of endogenous prostanoids and may be mediated by protein kinase C-dependent pathway. These results also show that the contractile response to vanadate on the rat aorta is impaired during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8927030     DOI: 10.1007/bf01075930

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Vanadate inhibition of the Ca2+-dependent conformational change of the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Y Dupont; N Bennett
Journal:  FEBS Lett       Date:  1982-03-22       Impact factor: 4.124

2.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Effects of vanadate on mechanical responses and Na-K pump in vascular smooth muscle.

Authors:  H Ozaki; N Urakawa
Journal:  Eur J Pharmacol       Date:  1980-12-05       Impact factor: 4.432

4.  Circulatory changes during pregnancy in spontaneously and renal hypertensive rats.

Authors:  Y Lundgren; K Karlsson; U Ljungblad
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

5.  Role of volume in the regulation of vasopressin secretion during pregnancy in the rat.

Authors:  W M Barron; B A Stamoutsos; M D Lindheimer
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Prostaglandin- or endothelium-mediated vasodilation is not involved in the blunted responses of blood vessels to vasoconstrictors in pregnant rats.

Authors:  J St-Louis; B Sicotte
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

7.  Effects of sodium vanadate on the smooth muscle of the rat portal vein.

Authors:  K Shimamura; S Sunano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

Review 8.  Minireview: physiological and pharmacological properties of vanadium.

Authors:  B S Jandhyala; G J Hom
Journal:  Life Sci       Date:  1983-10-03       Impact factor: 5.037

9.  Regulation of vascular and gastric smooth muscle contractility by pervanadate.

Authors:  A Laniyonu; M Saifeddine; S Ahmad; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Alteration by vanadate of contractility in vascular and intestinal smooth muscle preparations.

Authors:  P M Hudgins; G H Bond
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

View more
  4 in total

1.  Multiple actions of halothane on contractile response to noradrenaline in isolated mesenteric resistance arteries.

Authors:  J Yoshino; T Akata; K Izumi; S Takahashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

Review 2.  Protein tyrosine phosphorylation in cardiovascular system.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

Review 3.  Smooth muscle contractility and protein tyrosine phosphorylation.

Authors:  A K Srivastava; J St-Louis
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Decavanadate possesses alpha-adrenergic agonist activity and a structural motif common with trans-beta form of noradrenaline.

Authors:  B V Venkataraman; H N Ravishankar; A V Rao; P Kalyani; G Sharada; K Namboodiri; B Gabor; T Ramasarma
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.